[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-356867-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-356867-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","inflammation-and-colorectal-cancer-pathogenesis-therapy-response-and-resistances","Inflammation and Colorectal Cancer Pathogenesis - Therapy Response and Resistances","","Colorectal cancer (CRC) is a major global health threat, commonly diagnosed and responsible for substantial cancer-related mortality. Improved screening, including liquid biopsies, strengthens early detection and survival. This review consolidates CRC biology by linking genetic heterogeneity, tumor microenvironment complexity, and gut microbiota dysfunction with disease initiation and progression. It emphasizes risk drivers such as age, chronic illness, and lifestyle choices. Treatment strategies across surgery, chemo-radiotherapy, targeted and immune approaches face obstacles from heterogeneity and therapy resistance, highlighting the need for personalized care based on intrinsic and extrinsic determinants involving immune-metabolic and dietary influences.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/inflammation-and-colorectal-cancer-pathogenesis-therapy-response-and-resistances/356867/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/inflammation-and-colorectal-cancer-pathogenesis-therapy-response-and-resistances/356867.png","ImageObject",300,407,{"name":42,"@type":43},"Pentious","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What key biological factors does the review connect to colorectal cancer progression?","Question",{"text":63,"@type":64},"It links CRC progression to genetic heterogeneity, the tumor microenvironment, and gut microbiota dysbiosis, alongside nutritional and metabolic alterations.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How do risk factors contribute to colorectal cancer development according to the text?",{"text":68,"@type":64},"Risk is associated with age, genetic changes, chronic diseases such as inflammatory bowel disease, and lifestyle factors including diet, alcohol use, smoking, and lack of exercise.",{"name":70,"@type":61,"acceptedAnswer":71},"What challenges are highlighted for therapy and resistance in colorectal cancer?",{"text":72,"@type":64},"The review notes that tumor heterogeneity and mechanisms within the supportive tumor microenvironment can impair treatment effectiveness and drive therapy resistance.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},356867,1790241072,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Review  \nInflammation and Colorectal Cancer Pathogenesis: Molecular, Immunological, and Environmental Features for Therapy Response and Resistances  \nBarbara Seliger 1,2,3,4,5,*, Rene Mantke 6, Norbert Naß 3,7, Werner Dammermann 2,3,8, Soeren Ocvirk 9,10, Janine Kah 2,3,8,11, Thomas Kalinski 7 and Chiara Massa 1,2,3,4  \nAcademic Editors: Michael Philipp Bachmann and Holger Stephan  \nReceived: 2 April 2026  \nRevised: 6 May 2026  \nAccepted: 8 May 2026  \nPublished: 12 May 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Institute of Translational Immunology, Brandenburg Medical School “Theodor Fontane”,  \n14770 Brandenburg an der Havel, Germany; chiara.massa@mhb-fontane.de  \n2 Faculty of Health Sciences Brandenburg, Brandenburg Medical School “Theodor Fontane”,  \n14770 Brandenburg an der Havel, Germany; werner.dammermann@mhb-fontane.de (W.D.); [janine.kah@mhb-fontane.de](janine.kah@mhb-fontane.de) (J.K.)  \n3 Centre for Translational Medicine, Brandenburg Medical School “Theodor Fontane”,  \n14770 Brandenburg an der Havel, Germany; [norbert.nass@mhb-fontane.de](norbert.nass@mhb-fontane.de)  \n4 Section of Immunopathology, Institute of Pathology, Martin-Luther-University Halle-Wittenberg, 06112 Halle (Saale), Germany  \n5 Fraunhofer Institute for Cell Therapy and Immunology, 04103 Leipzig, Germany  \n6 Clinic for General and Visceral Surgery, University Hospital Brandenburg, Brandenburg Medical School“Theodor Fontane”, 14770 Brandenburg an der Havel, Germany; mantke.mhb@uk-brandenburg.de  \n7 Department of Pathology, University Hospital Brandenburg, Brandenburg Medical School “Theodor Fontane”, 14770 Brandenburg an der Havel, Germany; thomas.kalinski@uk-brandenburg.de  \n8 Department of Gastroenterology, University Hospital Brandenburg, Brandenburg Medical School “Theodor Fontane”, 14770 Brandenburg an der Havel, Germany  \n9 Gnotobiology Research Unit, German Institute of Human Nutrition Potsdam-Rehbruecke,  \n14558 Nuthetal, Germany; [soeren.ocvirk@dife.de](soeren.ocvirk@dife.de)  \n10 Research Group WESTGUT, ZIEL, Institute for Food & Health, Technical University of Munich,  \n85354 Freising, Germany  \n11 Department of Medicine, University Medical Center Hamburg-Eppendorf, 20251 Hamburg, Germany  \n* Correspondence: barbara.seliger@mhb-fontane.de; Tel.: +49-3381-2182216  \nAbstract  \nColorectal cancer (CRC) is a significant global health concern, ranking as the third most frequently diagnosed cancer and the second leading cause of cancer-related deaths. Advances in screening, such as the implementation of liquid biopsies (LB), have improved early detection, thus enhancing survival rates. This review summarizes the multifaceted nature of CRC, focusing on its genetic background, the complex tumor microenvironment, and the influence of gut microbiota, nutrition, and metabolic alterations. The development of CRC is influenced by various risk factors, including age, genetics, chronic diseases, and lifestyle choices. The genetic heterogeneity of CRC defines distinct molecular subtypes, characterized by different treatment responses and patient prognoses. Chronic inflammation and dysbiosis in the gut microbiota further contribute to CRC pathogenesis. In addition, nutritional factors play a crucial role in CRC, affecting carcinogenesis and treatment efficacy through direct interaction with the immune system and microbiome. Current therapeutic strategies include surgical interventions, chemo-and radiotherapy, targeted therapies, immunotherapy as well as dietary interventions, and microbiome modulation, highlighting the challenges posed by tumor heterogeneity and treatment resistance. In sum, a comprehensive understanding of CRC’s intrinsic and extrinsic drivers, including genetic, metabolic, and dietary influences, is essential for developing personalized treatment strategies and improv","cbCaidjnQ4DtkAg8","https://ap.wps.com/l/cbCaidjnQ4DtkAg8","pdf",538775,32,"English","# Abstract\n# 1. Introduction\n# 2. CRC Development","[{\"question\":\"What key biological factors does the review connect to colorectal cancer progression?\",\"answer\":\"It links CRC progression to genetic heterogeneity, the tumor microenvironment, and gut microbiota dysbiosis, alongside nutritional and metabolic alterations.\"},{\"question\":\"How do risk factors contribute to colorectal cancer development according to the text?\",\"answer\":\"Risk is associated with age, genetic changes, chronic diseases such as inflammatory bowel disease, and lifestyle factors including diet, alcohol use, smoking, and lack of exercise.\"},{\"question\":\"What challenges are highlighted for therapy and resistance in colorectal cancer?\",\"answer\":\"The review notes that tumor heterogeneity and mechanisms within the supportive tumor microenvironment can impair treatment effectiveness and drive therapy resistance.\"}]","Inflammation and Colorectal Cancer Pathogenesis - Therapy Response and Resistances | PDF",1790127801,81,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8d719d85d86de77f822200da9f6d5db8.webp",983,1390,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3073897685f535ff6b38cc279540f35b.webp",982,1388,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/477fd5cacabddf2a354da27eec15b114.webp",981,1387,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6c5dcd367011154ffd201c94361f0ee7.webp",980,1385]